UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000009086
Receipt number R000010278
Scientific Title Cohort study evaluating efficacy of bevacizumab plus paclitaxel in patients with HER2-negative inoperable or metastatic breast cancer(JBCRG-C05)
Date of disclosure of the study information 2012/10/12
Last modified on 2021/08/18 09:27:07

No. Disposal Last modified on Item of update
1 Insert 2012/10/11 11:37:16
2 Update 2012/12/14 11:46:28 Recruitment status
3 Update 2013/06/17 16:45:48 Acronym
Acronym
4 Update 2013/06/17 16:46:26 Recruitment status
5 Update 2014/04/30 15:51:07 TEL
Email
6 Update 2016/07/08 15:38:14 Recruitment status
7 Update 2016/11/04 18:17:43 Organization
Organization
Address
Address
TEL
Name of primary person or sponsor
Organization
8 Update 2016/11/04 18:18:31 Last follow-up date
Publication of results
9 Update 2018/08/24 10:06:39 UMIN ID1
UMIN ID2
10 Update 2019/09/05 14:28:41 Key exclusion criteria
11 Update 2019/09/05 14:34:02 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Zip code
Address
Address

Last name of contact person

Last name of contact person
Zip code
Address
Address
Organization
Organization
Organization
Address
Address
Tel
Email
12 Update 2019/09/05 14:37:00 Publication of results
Number of participants that the trial has enrolled
Results Delayed
Results Delay Reason
Results Delay Reason
13 Update 2019/09/05 14:41:58 Date of IRB
14 Update 2021/07/15 14:13:02
Last name of contact person

Last name of contact person
Division name
Address
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
15 Update 2021/07/15 15:47:08 Homepage URL
16 Update 2021/08/05 17:47:26 Recruitment status
17 Update 2021/08/18 09:27:07 URL releasing protocol
Publication of results
URL related to results and publications
Results
Results
Results date posted
Results Delayed
Results Delay Reason
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures